Apnimed APMD
$16.09 −$1.16 (-6.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $16.09 0.00%
Open$17.08
Prev close$17.25
Day range$15.95 – $17.73
Volume248.6K
Market cap$669.84M
P/E (TTM)4.1
Dividend yield–
APMD Stock News
Headlines matching Apnimed or the APMD ticker, most recent first.
- LifeSci Capital Maintains Apnimed(APMD.US) With Buy Rating, Maintains Target Price $50
- A Quick Look at Today's Ratings for Apnimed(APMD.US), With a Forecast Between $41 to $60
- Evercore Initiates Apnimed(APMD.US) With Buy Rating
- LifeSci Capital Initiates Apnimed(APMD.US) With Buy Rating, Announces Target Price $50
- BofA Securities Initiates Apnimed(APMD.US) With Buy Rating, Announces Target Price $41
- U.S. Stocks Move | Apnimed (APMD.US), a developer of drugs for sleep apnea, debuts on the U.S. stock market, with shares rising over 11% at the open. Positive
- BofA Securities Maintains Apnimed(APMD.US) With Buy Rating, Maintains Target Price $41
- Bank of America Securities Remains a Buy on Apnimed, Inc. (APMD)
No comments yet — be the first to weigh in on APMD.
Sign in to join the discussion.